nandrolone decanoate has been researched along with Cardiomyopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allem, R; Kahal, A | 1 |
| Chekodanova, NV; Chekunova, MP; Minkina, NA; Suvorov, IM; Zenkevich, ES | 1 |
| Davis, WM; Lin, TL; Long, SF | 1 |
3 other study(ies) available for nandrolone decanoate and Cardiomyopathies
| Article | Year |
|---|---|
Reversible effects of anabolic steroid abuse on cyto-architectures of the heart, kidneys and testis in adult male mice.
Topics: Anabolic Agents; Animals; Cardiomyopathies; Cardiotoxicity; Heart; Kidney; Male; Mice; Muscle Strength; Myocardium; Nandrolone Decanoate; Organ Size; Risk Assessment; Substance-Related Disorders; Testis; Time Factors; Weight Gain | 2018 |
[Pathogenetic therapy of cobalt-induced cardiomyopathies].
Topics: Adrenergic beta-Antagonists; Anabolic Agents; Animals; Cardiomyopathies; Cobalt; Drug Evaluation, Preclinical; Levodopa; Male; Nandrolone; Nandrolone Decanoate; Nialamide; Propranolol; Rats; Succinates; Sulfhydryl Compounds | 1980 |
Nandrolone decanoate reduces the premature mortality of cardiomyopathic hamsters.
Topics: Anabolic Agents; Animals; Body Weight; Cardiomyopathies; Cricetinae; Injections, Subcutaneous; Liver; Male; Mesocricetus; Myocardium; Nandrolone; Nandrolone Decanoate; Survival Rate | 1993 |